Kodiak Sciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome everyone to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team. Our next presenting company is Kodiak Sciences, and speaking on behalf of the company, we have CEO, Victor Perlroth.
Before I turn it to Victor, I just wanted to highlight for those listening on the webcast, you can submit a question by the Ask a Question feature in the portal, and I recommend everyone to do that. Victor?
Hi, Anupam. Thank you. It's my pleasure to be here at the conference to present Kodiak as a company, our lead product, KSI-301 and its accelerating development plan and our ABC Platform with the deepening pipeline of medicines focused for retina diseases. Yes. I think we'll move forward with about a 15- or 20-minute presentation, and then we'll save time for questions.
Let's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |